OncoResponse Revenue and Competitors
Claim your profile
Estimated Revenue & Valuation
- OncoResponse's estimated annual revenue is currently $2.9M per year.
- OncoResponse's estimated revenue per employee is $81,600
Employee Data
- OncoResponse has 36 Employees.
OncoResponse Competitors & Alternatives
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.1M | 2 | N/A | N/A | N/A |
#2 | $0.3M | 5 | N/A | N/A | N/A |
#3 | $741.1M | 5190 | 8% | N/A | N/A |
#4 | $1.6M | 23 | N/A | N/A | N/A |
#5 | $2.5M | 31 | -42% | N/A | N/A |
#6 | $3.8M | 46 | -39% | N/A | N/A |
#7 | $2.9M | 36 | N/A | N/A | N/A |
#8 | $1.5M | 21 | -19% | N/A | N/A |
#9 | $0.9M | 15 | N/A | N/A | N/A |
#10 | $5.8M | 63 | -2% | N/A | N/A |
What Is OncoResponse?
OncoResponse leverages the power of the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer. Through our partnership with MD Anderson Cancer Center, we deploy a unique and transformative approach to the discovery of cancer therapeutics. OncoResponse is based in Seattle, Washington.
keywords:N/A
N/A
Total Funding
36
Number of Employees
$2.9M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
OncoResponse News
2022-03-22 - OncoResponse Announces Oral Presentation at Festival of ...
OncoResponse is a clinical-stage, immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11M | 36 | N/A | N/A |
#2 | $5.2M | 36 | N/A | N/A |
#3 | $7M | 36 | 9% | N/A |
#4 | $4.2M | 36 | N/A | N/A |
#5 | N/A | 36 | N/A | N/A |
